Augmedics, Inc., a pioneering force in the medical technology sector, is headquartered in the United States. Founded in 2014, the company has rapidly established itself as a leader in augmented reality (AR) solutions for surgical applications, particularly in the field of spinal surgery. With a focus on enhancing surgical precision, Augmedics offers its flagship product, the Xvision Spine System, which uniquely integrates AR technology to provide surgeons with real-time, 3D visualisation of a patient's anatomy during procedures. This innovative approach not only improves surgical outcomes but also enhances patient safety. Recognised for its groundbreaking contributions, Augmedics continues to expand its operational reach, aiming to transform the landscape of surgical practices globally. The company’s commitment to advancing medical technology positions it as a notable player in the healthcare industry.
How does Augmedics, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Augmedics, Inc.'s score of 23 is lower than 70% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Augmedics, Inc., headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Augmedics may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. In the context of the broader industry, many companies are increasingly adopting science-based targets and sustainability practices to mitigate climate change impacts. However, without specific emissions data or commitments, it is unclear how Augmedics aligns with these trends. As the company continues to operate, it may consider developing a strategy to address carbon emissions and enhance its environmental responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Augmedics, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
